The Cost of Cancer Care Team


We are a group of healthcare professionals and researchers working to better understand the cost of cancer care and its impact on your quality of life.

The Cost of Cancer Care Team

HeadShotJonas_0_0.jpegJonas A. de Souza, MD, MBA

Jonas de Souza, MD, is the project leader of the Cost of Cancer Care Project. He developed the COmprehensive Score for financial Toxicity (COST), and created its registry. Dr. de Souza specializes in the treatment of head and neck cancer, including thyroid and squamous cell carcinomas. His research focuses on the use of novel therapeutic agents along with measurements of financial burden, patients' preferences, and the trade-offs between the risks and benefits of cancer therapies. 

View Dr. Jonas de Souza's LinkedIn profile View Dr. Jonas de Souza's profile

Ellie-Proussaloglou.jpgEllie Proussaloglou

Ellie Proussaloglou is a second year medical student at the University of Chicago Pritzker School of Medicine with an academic background in cancer genomics and prior work experience in strategy consulting for the pharmaceutical and biotechnology industries. She is interested in incorporating an understanding of the costs of treatment into a future career in cancer care.

View Ellie Proussaloglou 's LinkedIn profile View Ellie Proussaloglou's profile

Collaborators and Advisors

Chadi.Nabhan1_0.pngChadi Nabhan, MD, FACP

Chadi Nabhan, MD, MBA, FACP, is the chief medical officer of Cardinal Health. Dr. Nabhan specializes in the diagnosis and management of hematologic malignancies (leukemias and lymphomas) as well as prostate cancer. 

View Dr. Chadi Nabhan's LinkedIn profile View Dr. Chadi Nabhan's profile

Brisa_0.jpgBrisa Aschebrook-Kilfoy, PhD, MPH

Brisa Aschebrook-Kilfoy, PhD, MPH is a cancer epidemiologist at the University of Chicago in the Center for Cancer Epidemiology and Prevention. She is a co-principal investigator of a large thyroid cancer survivorship cohort- The North American Thyroid Cancer Survivorship Study. Her research focuses on understanding the quality-of-life outcomes for cancer survivors in addition to the environmental etiology of cancer.  

Kircher-Sheetal-MD-Hematology-Oncology-LBP3601%20%282%29%5B1%5D_0.jpgSheetal Kircher, MD

Sheetal Kircher, MD, is a medical oncologist who specializes in the treatment of gastrointestinal malignancies at Northwestern University. She is working to expand cancer survivorship services and study the late effects of chemotherapy. Her research also focuses on understanding the impact of cancer policy on healthcare costs.  

Chris_0.pngChristopher Daugherty, MD

Christopher Daugherty, MD, is a medical oncologist and the University of Chicago’s Director of the Supportive Oncology Program which provides comprehensive multidisciplinary clinical supportive care for cancer patients. His research expertise focuses on ethical issues in cancer care and clinical research.  

Fay_0.pngFay Hlubocky, PhD, MA

Fay Hlubocky, MD, is a clinical health psychologist and research ethicist at the University of Chicago. Her research activities are centered on the psychosocial needs and ethical concerns surrounding cancer patients and caregivers  

JeremyShot_0.pngJeremy O'Connor, MD

Jeremy O'Connor is a National Clinician Scholars post-doctoral fellow at Yale. Dr. O'Connor is interested in the relationship between health policy decisions and cancer outcomes, with a particular emphasis on racial and socioeconomic disparities.